S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself

Amundi Stock Price, News & Analysis (OTCMKTS:AMDUF)

$54.00
0.00 (0.00%)
(As of 11/29/2023 ET)
Compare
Today's Range
$54.00
$54.00
50-Day Range
$54.00
$57.42
52-Week Range
$54.00
$60.45
Volume
N/A
Average Volume
2,225 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

AMDUF stock logo

About Amundi Stock (OTCMKTS:AMDUF)

Amundi is a publically owned investment manager. The firm engages in the asset management business. The company provides a range of retail products and solutions through quasi-exclusive distribution agreements with the retail banking networks of the Crédit Agricole and the Société Générale groups in France; and through international partner networks and joint ventures outside France, as well as through third-party distributors primarily in France, rest of Europe, and Asia. It also offers management and advisory services for various pension funds, insurers, and sovereigns; and treasury management and employee savings solutions for corporate customers through global relationship managers supported by sales and marketing staff in 30 countries. It was formerly known as Amundi Group. The company was founded in 1982 and is headquartered in Paris, France. Amundi Group operates as a subsidiary of Credit Agricole S.A.

AMDUF Stock Price History

AMDUF Stock News Headlines

Amundi Cac 40 Esg Share Price (C4D.PA)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Amundi Physical Gold Etc Share Price (GOLD.PA)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Amundi SA AMUN
Amundi: Third Quarter & 9 Months 2023 Results
NH-Amundi HANARO 200 ETF (293180)
Amundi: Appointments
See More Headlines
Receive AMDUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amundi and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
Current Symbol
OTCMKTS:AMDUF
CIK
N/A
Fax
N/A
Employees
5,400
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Ms. Valerie Baudson (Age 52)
    Group Chief Executive Officer
    Comp: $2.11M
  • Mr. Nicolas Calcoen (Age 50)
    Deputy CEO and Head of Strategy, Finance & Control Division
    Comp: $1.02M
  • Ms. Aurelia Lecourtier
    Chief Financial Officer
  • Mr. Guillaume Lesage
    Chief Operating Officer
  • Mr. Vincent Mortier
    Chief Investment Officer
  • Mr. Anthony Mellor
    Head of Investor Relations & Financial Communication
  • Catherine Chabrel
    Head of Compliance
  • Natacha Andermahr
    Head of Communication
  • Mr. Eric Bramoulle
    Head of Marketing & Product
  • Mr. Thierry Ancona
    Head of Sales, Third Party Distributors & Wealth














AMDUF Stock Analysis - Frequently Asked Questions

How have AMDUF shares performed in 2023?

Amundi's stock was trading at $56.6263 at the beginning of 2023. Since then, AMDUF shares have decreased by 4.6% and is now trading at $54.00.
View the best growth stocks for 2023 here
.

Are investors shorting Amundi?

Amundi saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 4,300 shares, an increase of 152.9% from the October 31st total of 1,700 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 43.0 days.
View Amundi's Short Interest
.

How do I buy shares of Amundi?

Shares of AMDUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:AMDUF) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -